Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 18,957	$ 34,347
Restricted cash	1,804	3,969
Accounts receivable - trade, net of allowance for credit losses of $20,449 as of December 31, 2023 and $16,184 as of December 31, 2022	70,477	134,471
Other receivables	13,217	16,144
Inventories	82,227	94,288
Contract assets	825	576
Prepaid expenses and other current assets	8,861	7,410
Total current assets	196,368	291,205
Property, plant and equipment, net	5,723	9,478
Right-of-use assets from operating leases	7,135	12,606
Goodwill	0	12,594
Intangible assets, net	25,484	31,742
Other assets	14,671	15,536
Total assets	249,381	373,161
Current liabilities:
Accounts payable - trade	83,914	118,667
Short-term debt - bank, trade facilities and secured borrowings	19,633	9,706
Current portion of long-term debt	0	24,073
Contract liabilities	15,990	18,705
Operating lease liabilities	4,590	4,834
Accrued and other liabilities	41,684	25,562
Total current liabilities	165,811	201,547
Long-term debt	37,908	0
Contract liabilities - non-current	3,712	7,788
Operating lease liabilities - non-current	5,611	11,417
Pension liabilities	11,802	11,021
Other long-term liabilities	1,978	2,806
Total liabilities	226,822	234,579
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, 72,000 and 36,000 shares authorized, 32,122 and 30,968 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively, at $0.001 par value	31	30
Preferred stock, $0.001 par value, 25,000 shares authorized and no shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively
Additional paid-in capital	294,863	271,884
Accumulated other comprehensive loss	(8,447)	(4,662)
Accumulated deficit	(263,888)	(128,670)
Total stockholders’ equity	22,559	138,582
Total liabilities and stockholders’ equity	$ 249,381	$ 373,161